“…The ideal prophylactic agent would reduce the number of patients who develop postoperative atrial fibrillation, reduce the number of episodes per patient, provide ventricular rate control among patients who develop atrial fibrillation, be applicable to all patients, and have a low side effect profile. Despite the availability of several antiarrhythmic drugs for the treatment of atrial fibrillation, only a few have been evaluated as prophylactic agents in the postoperative setting; these include digitalis [10][11][12][13], magnesium [14][15], verapamil [16], procainamide [17], sotalol [18][19][20][21][22], and amiodarone [23][24][25][26] (Table). …”